Follow
Oscar Goodman
Title
Cited by
Cited by
Year
Abiraterone and increased survival in metastatic prostate cancer
JS De Bono, CJ Logothetis, A Molina, K Fizazi, S North, L Chu, KN Chi, ...
New England Journal of Medicine 364 (21), 1995-2005, 2011
52192011
β-Arrestin acts as a clathrin adaptor in endocytosis of the β2-adrenergic receptor
OB Goodman Jr, JG Krupnick, F Santini, VV Gurevich, RB Penn, ...
nature 383 (6599), 447-450, 1996
18121996
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo …
K Fizazi, HI Scher, A Molina, CJ Logothetis, KN Chi, RJ Jones, ...
The lancet oncology 13 (10), 983-992, 2012
17672012
Arrestin/clathrin interaction: Localization of the clathrin binding domain of nonvisual arrestins to the carboxyl terminus
JG Krupnick, OB Goodman, JH Keen, JL Benovic
Journal of Biological Chemistry 272 (23), 15011-15016, 1997
3551997
Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration-resistant …
CJ Logothetis, E Basch, A Molina, K Fizazi, SA North, KN Chi, RJ Jones, ...
The lancet oncology 13 (12), 1210-1217, 2012
3312012
Arrestin/clathrin interaction: localization of the arrestin binding locus to the clathrin terminal domain
OB Goodman, JG Krupnick, VV Gurevich, JL Benovic, JH Keen
Journal of Biological Chemistry 272 (23), 15017-15022, 1997
2981997
Niraparib and abiraterone acetate for metastatic castration-resistant prostate cancer
KN Chi, D Rathkopf, MR Smith, E Efstathiou, G Attard, D Olmos, JY Lee, ...
Journal of Clinical Oncology 41 (18), 3339-3351, 2023
2212023
Comparison of circulating MicroRNA 141 to circulating tumor cells, lactate dehydrogenase, and prostate-specific antigen for determining treatment response in patients with …
JC Gonzales, LM Fink, OB Goodman Jr, JT Symanowski, NJ Vogelzang, ...
Clinical genitourinary cancer 9 (1), 39-45, 2011
1682011
Circulating tumor cells in patients with castration-resistant prostate cancer baseline values and correlation with prognostic factors
OB Goodman Jr, LM Fink, JT Symanowski, B Wong, B Grobaski, ...
Cancer Epidemiology Biomarkers & Prevention 18 (6), 1904-1913, 2009
1362009
Circulating tumor cells as a predictive biomarker in patients with hormone-sensitive prostate cancer
OB Goodman Jr, JT Symanowski, A Loudyi, LM Fink, DC Ward, ...
Clinical genitourinary cancer 9 (1), 31-38, 2011
1272011
A phase 1 study of a vaccine targeting preferentially expressed antigen in melanoma and prostate-specific membrane antigen in patients with advanced solid tumors
JS Weber, NJ Vogelzang, MS Ernstoff, OB Goodman, LD Cranmer, ...
Journal of immunotherapy 34 (7), 556-567, 2011
1162011
Mapping of the molecular determinants involved in the interaction between eps15 and AP-2
G Iannolo, AE Salcini, I Gaidarov, OB Goodman Jr, J Baulida, G Carpenter, ...
Cancer research 57 (2), 240-245, 1997
1131997
Exploratory analysis of the visceral disease subgroup in a phase III study of abiraterone acetate in metastatic castration-resistant prostate cancer
OB Goodman, TW Flaig, A Molina, PFA Mulders, K Fizazi, H Suttmann, ...
Prostate cancer and prostatic diseases 17 (1), 34-39, 2014
1122014
Synergistic loss of prostate cancer cell viability by coinhibition of HDAC and PARP
OS Chao, OB Goodman Jr
Molecular cancer research 12 (12), 1755-1766, 2014
1032014
Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells
J Gong, J Zhu, OB Goodman, RG Pestell, PN Schlegel, DM Nanus, ...
Oncogene 25 (14), 2011-2021, 2006
902006
Detection of lipid-rich prostate circulating tumour cells with coherent anti-Stokes Raman scattering microscopy
R Mitra, O Chao, Y Urasaki, OB Goodman, TT Le
BMC cancer 12, 1-9, 2012
892012
Efficacy and safety of telaglenastat plus cabozantinib vs placebo plus cabozantinib in patients with advanced renal cell carcinoma: the CANTATA randomized clinical trial
NM Tannir, N Agarwal, C Porta, NJ Lawrence, R Motzer, B McGregor, ...
JAMA oncology 8 (10), 1411-1418, 2022
872022
Apalutamide plus abiraterone acetate and prednisone versus placebo plus abiraterone and prednisone in metastatic, castration-resistant prostate cancer (ACIS): a randomised …
F Saad, E Efstathiou, G Attard, TW Flaig, F Franke, OB Goodman, ...
The Lancet Oncology 22 (11), 1541-1559, 2021
862021
Role of arrestins in G-protein-coupled receptor endocytosis
OB Goodman Jr, JG Krupnick, F Santini, VV Gurevich, RB Penn, ...
Advances in pharmacology 42, 429-433, 1997
841997
The α Chain of the AP-2 Adaptor Is a Clathrin Binding Subunit (∗)
OB Goodman, JH Keen
Journal of Biological Chemistry 270 (40), 23768-23773, 1995
771995
The system can't perform the operation now. Try again later.
Articles 1–20